{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:16:59Z","timestamp":1784128619352,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochirurgie"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neuchi.2021.04.018","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T12:20:27Z","timestamp":1620735627000},"page":"556-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome"],"prefix":"10.1016","volume":"67","author":[{"given":"T.","family":"Graillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-6628","authenticated-orcid":false,"given":"S.","family":"Boissonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boucekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Peyri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Albarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-8800","authenticated-orcid":false,"given":"F.","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-887X","authenticated-orcid":false,"given":"D.","family":"Figarella-Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-0030","authenticated-orcid":false,"given":"T.","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuchi.2021.04.018_bib0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2176\/nmc.48.227","article-title":"Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration","volume":"48","author":"Shimizu","year":"2008","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/jovr.jovr_21_17","article-title":"Regression of Giant Olfactory Groove Meningioma and Complete Visual Acuity Recovery after Discontinuation of Cyproterone Acetate","volume":"13","author":"Bernat","year":"2018","journal-title":"J Ophthalmic Vis Res"},{"issue":"11","key":"10.1016\/j.neuchi.2021.04.018_bib0265","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00701-010-0787-2","article-title":"Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient","volume":"152","author":"Cebula","year":"2010","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.018_bib0270","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3171\/jns.2003.99.5.0848","article-title":"Sex steroid hormone exposures and risk for meningioma","volume":"99","author":"Jhawar","year":"2003","journal-title":"J Neurosurg"},{"issue":"8","key":"10.1016\/j.neuchi.2021.04.018_bib0275","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3174\/ajnr.A1978","article-title":"Abrupt regression of a meningioma after discontinuation of cyproterone treatment","volume":"31","author":"Goncalves","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.018_bib0280","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","article-title":"Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study","volume":"72","author":"Gil","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3171\/2012.9.JNS12811","article-title":"Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females","volume":"118","author":"Claus","year":"2013","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canep.2011.08.003","article-title":"Hormonal therapies and meningioma: is there a link?","volume":"36","author":"Cea-Soriano","year":"2012","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.018_bib0295","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuchi.2015.05.002","article-title":"[Intra cranial meningiomas and long term use of cyproterone acetate with a conventional dose in women. A report of two cases of tumor decrease after treatment withdrawal]","volume":"61","author":"Botella","year":"2015","journal-title":"Neurochirurgie"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-020-03672-9","article-title":"Cyproterone acetate and meningioma: a nationwide-wide population based study","volume":"151","author":"Champeaux-Depond","year":"2021","journal-title":"J Neurooncol"},{"issue":"37","key":"10.1016\/j.neuchi.2021.04.018_bib1300","article-title":"Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study","volume":"372","author":"Weill","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0305","series-title":"Computerized matching of controls","author":"Bergstrahl","year":"1995"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.018_bib0310","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/026886900417388","article-title":"Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy","volume":"14","author":"Hensiek","year":"2000","journal-title":"Br J Neurosurg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0315","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3171\/jns.2004.100.2.0328","article-title":"Multiple meningiomas arising during long-term therapy with the progesterone agonist megestrol acetate. Case report","volume":"100","author":"Gruber","year":"2004","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.018_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2011.03.035","article-title":"Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy","volume":"76","author":"Gruber","year":"2011","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.018_bib0325","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3171\/2009.8.JNS09201","article-title":"Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy","volume":"112","author":"Vadivelu","year":"2010","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0330","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00701-018-03782-4","article-title":"Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report","volume":"161","author":"Champagne","year":"2019","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10.1016\/j.neuchi.2021.04.018_bib0335","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.018_bib0340","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00701-019-03848-x","article-title":"Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients","volume":"161","author":"Passeri","year":"2019","journal-title":"Acta Neurochir (Wien)"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.018_bib0345","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/and.12550","article-title":"Meningiomas in three male-to-female transgender subjects using oestrogens\/progestogens and review of the literature","volume":"48","author":"Ter Wengel","year":"2016","journal-title":"Andrologia"},{"issue":"6","key":"10.1016\/j.neuchi.2021.04.018_bib0350","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/09513590.2017.1395839","article-title":"Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review","volume":"34","author":"Mancini","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/sni.sni_22_18","article-title":"Multiple meningiomas in two male-to-female transsexual patients with hormone replacement therapy: a report of two cases and a brief literature review","volume":"9","author":"Raj","year":"2018","journal-title":"Surg Neurol Int"},{"issue":"23","key":"10.1016\/j.neuchi.2021.04.018_bib0360","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMc071938","article-title":"Growth of a meningioma in a transsexual patient after estrogen-progestin therapy","volume":"357","author":"Gazzeri","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.018_bib0365","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-019-03147-6","article-title":"Fertility treatment is associated with multiple meningiomas and younger age at diagnosis","volume":"143","author":"Shahin","year":"2019","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0370","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13760-012-0046-9","article-title":"Hormonal therapy for fertility and huge meningioma: a purely random association?","volume":"112","author":"Frassanito","year":"2012","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0375","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuchi.2020.10.002","article-title":"Resected atypical meningioma relapsed to anaplastic meningioma during luteinizing hormone-releasing hormone agonist therapy","volume":"67","author":"Nicosia","year":"2020","journal-title":"Neurochirurgie"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0380","first-page":"351","article-title":"Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma","volume":"62","author":"Lee","year":"2003","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.018_bib0385","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2176\/nmc.cr2012-0417","article-title":"Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report","volume":"54","author":"Anda","year":"2014","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.018_bib0390","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/pcan.2013.45","article-title":"Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma","volume":"16","author":"Li","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2016.03.076","article-title":"Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer","volume":"91","author":"Tsutsui","year":"2016","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clineuro.2008.09.015","article-title":"Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas","volume":"111","author":"Hirota","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.018_bib0405","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1076\/13813455199908107041QFT286","article-title":"Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro","volume":"107","author":"Durmaz","year":"1999","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0410","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-008-9751-x","article-title":"Meningioma in untreated congenital adrenal hyperplasia: a relationship?","volume":"92","author":"Heijboer","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0415","article-title":"Growth of a progesterone receptor-positive meningioma in a female patient with congenital adrenal hyperplasia","volume":"2016","author":"O'Shea","year":"2016","journal-title":"Diabetes Metab Case Rep"},{"issue":"10","key":"10.1016\/j.neuchi.2021.04.018_bib0420","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","article-title":"Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients","volume":"157","author":"Bernat","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0425","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/annonc\/mdx763","article-title":"Progestin-associated shift of meningioma mutational landscape","volume":"29","author":"Peyre","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0430","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuchi.2015.12.006","article-title":"[Multiple meningiomas]","volume":"62","author":"Terrier","year":"2016","journal-title":"Neurochirurgie"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0435","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuchi.2019.12.013","article-title":"Symptomatic progestin-associated atypical grade II meningioma. A first case report","volume":"66","author":"Roux","year":"2020","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0440","doi-asserted-by":"crossref","first-page":"e918","DOI":"10.1016\/j.wneu.2018.07.100","article-title":"Progesterone Receptor Is Responsible for Benign Biology of Skull Base Meningioma","volume":"118","author":"Kuroi","year":"2018","journal-title":"World Neurosurg"},{"issue":"Suppl 1","key":"10.1016\/j.neuchi.2021.04.018_bib0445","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/humrep\/9.suppl_1.190","article-title":"Meningiomas, epidermal growth factor and progesterone","volume":"9","author":"Koper","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0450","series-title":"Physiology of GNRH and Gonadotropin Secretion","author":"Marques","year":"2000"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.018_bib0455","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3171\/2014.12.JNS142112","article-title":"Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report","volume":"124","author":"Kerschbaumer","year":"2016","journal-title":"J Neurosurg"},{"issue":"7","key":"10.1016\/j.neuchi.2021.04.018_bib0460","first-page":"825","article-title":"Neurosurgical, obstetric and endocrine aspects of meningioma during pregnancy","volume":"23","author":"Goldberg","year":"1987","journal-title":"Isr J Med Sci"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.018_bib0465","first-page":"46","article-title":"[Intracranial meningioma in pregnancy. Case report and literature review]","volume":"84","author":"Reyes-Myrna","year":"2016","journal-title":"Ginecol Obstet Mex"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.018_bib0470","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/1793-5482.181115","article-title":"Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy","volume":"13","author":"Gurcay","year":"2018","journal-title":"Asian J Neurosurg"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0475","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-021-03696-9","article-title":"Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience","volume":"152","author":"Malaize","year":"2021","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.neuchi.2021.04.018_bib0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00701-009-0492-1","article-title":"Determinants of postoperative visual recovery in suprasellar meningiomas","volume":"152","author":"Galal","year":"2010","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.neuchi.2021.04.018_bib0485","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.wneu.2010.08.021","article-title":"Surgical management and evaluation of prognostic factors influencing postoperative visual outcome of suprasellar meningiomas","volume":"75","author":"Wang","year":"2011","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.neuchi.2021.04.018_bib0490","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3171\/jns.1984.61.4.0642","article-title":"Surgical management of suprasellar meningioma. Part 2: Prognosis for visual function following craniotomy","volume":"61","author":"Rosenstein","year":"1984","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neuchi.2021.04.018_bib0495","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1016\/j.wneu.2019.05.253","article-title":"Surgery for Clinoidal Meningiomas: Case Series and Meta-Analysis of Outcomes and Complications","volume":"129","author":"Giammattei","year":"2019","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.neuchi.2021.04.018_bib0500","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cncr.22783","article-title":"Exogenous hormone use and meningioma risk: what do we tell our patients?","volume":"110","author":"Claus","year":"2007","journal-title":"Cancer"}],"container-title":["Neurochirurgie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377021001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377021001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:32:06Z","timestamp":1758436326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028377021001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0028377021001454"],"URL":"https:\/\/doi.org\/10.1016\/j.neuchi.2021.04.018","relation":{},"ISSN":["0028-3770"],"issn-type":[{"value":"0028-3770","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome","name":"articletitle","label":"Article Title"},{"value":"Neurochirurgie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuchi.2021.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}